Modified GRF (1-29) peptide
Modified GRF (1-29) is a real compound reported in scientific or clinical literature. Its inclusion is not a claim of safety, effectiveness or approval.
Use this Modified GRF (1-29) peptide record to separate compound identity, human evidence, regulatory status and COA quality. These are related but distinct questions.
What is Modified GRF (1-29)?
Modified GRF (1-29) is an analogue of growth hormone-releasing hormone.
What does it do?
It activates pituitary GHRH receptors and can increase pulsatile growth-hormone signalling and downstream IGF-1.
Current use and status
Only specific finished medicines have authorized indications; many related analogues remain investigational or research-labelled.
Investigational or research status; verify the current local regulator record.
What the evidence does not prove
Sequence, duration, formulation and clinical monitoring differ. Research products should not be inferred equivalent to an authorized medicine.
Certificate quality signals
- Certificate lot and label lot should agree
- Measured values should name their analytical method
- The issuing laboratory and report identifier should be independently traceable
Modified GRF (1-29) peptide reference records
Use the public chemistry and regulatory or clinical-study records to confirm identity and current product status. A database listing is not a product endorsement.
Learn how to assess peptide evidence
Read the peptide safety, sourcing and certificate-verification guides before interpreting a seller or laboratory claim.
Browse peptide guides